Experts' cancer rates are about six times higher in women than in men

The lifestyle of women today leads to many cancers
Cancer is a terrible disease that causes the death of many people around the world each year. Researchers now found that cancer rates in women will increase six times faster over the next twenty years than they do in men. One of the main reasons for this is the growing obesity.

Researchers at Cancer Research UK found in one study that cancer rates in women will increase much more in the future than in men. The doctors published a press release on the results of their study.

Cancer leads to many deaths worldwide. Women are particularly susceptible to some types of cancer. Researchers found that the cancer rate in women in the coming years will increase sharply. (Image: vitanovski / fotolia.com)

Ovarian cancer, cervical cancer and oral cancer will increase sharply
There are several types of obesity-related cancers that can only affect women, and today there is an increasing number of people of both sexes who are severely overweight, say the physicians. The most likely to increase rates of ovarian cancer, cervical cancer and oral cancer.

Breast cancer drug Palbociclib is not funded by the NHS
Cancer rates will rise by about 0.5 percent for men and 3 percent for women by 2035. These figures were released on the same day that the National Institute for Health and Care Excellence announced that the breast cancer drug Palbociclib should not be routinely funded by the NHS in England.

Many women should change their lifestyle
Charities condemned this decision, emphasizing that more therapies need to be developed and supported to help breast cancer survivors. They also called for women to change their lifestyle. So women could minimize the risk.

Research should allow better survival in difficult to treat cancer
The new numbers reflect the huge challenge we face both in the UK and globally, experts at Cancer Research UK explain. "We really need to work hard to prevent the devastating effects of cancer on many women and their families," the researchers emphasize. Especially with difficult-to-treat cancer, research must enable many more patients to survive the disease.

New treatments could save the lives of three out of four people
The latest figures show that more than eight million people die of cancer every year worldwide. Cancer kills more people than AIDS, malaria and tuberculosis, explain the experts. With more investment in research, major improvements in the diagnosis of cancer would be possible over the next 20 years, and new treatments could be developed that could save three out of four cancer patients by 2034, the researchers say.

What are other risk factors?
Smoking is another factor behind the predicted growth of cancer cases in women. In women, smoking is still widespread. Also, lack of exercise and alcohol consumption lead to the predicted increase in cancers, say the scientists.

Rates of uterine cancer and ovarian cancer could be slightly reduced
It is frightening that the cancer rate in women will increase so much, especially because so many of these cancer cases could be prevented, the researchers explain. For example, about two out of five breast cancers in the UK could be prevented if women were more physically active, were healthy and did not drink alcohol. That would be about 20,000 fewer cases per year. Other cancers can also be reduced by a healthier lifestyle. These include, for example, uterine cancer and ovarian cancer. Women should also regularly participate in cancer screening, experts suggest.

Medicines need to be cheaper
It is also important that anti-cancer medicines are offered at a low price. In England, palbociclib may be considered as a treatment for some 5,000 people (out of 45,000 breast cancer diagnoses annually), the experts speculate. So far, however, prevent the high price of the drug many of the treatments. This is the clearest illustration so far that the drug evaluation system is completely inappropriate for the purpose of breast cancer drug evaluation.

Palbociclib is effective but still too expensive
Much of the metastatic breast cancer patients would benefit from the use of palbociclib, the experts explain. Palbociclib has been one of the major advances in the treatment of breast cancer in the last 20 years. It would therefore be important for this type of treatment to be made available to as many patients as possible. (As)